nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CES2—Irinotecan—breast cancer	0.167	0.328	CbGbCtD
Prasugrel—CYP3A4—breast cancer	0.125	0.534	CbGaD
Prasugrel—ALB—breast cancer	0.109	0.466	CbGaD
Prasugrel—CYP2B6—Thiotepa—breast cancer	0.033	0.0645	CbGbCtD
Prasugrel—CYP2C9—Anastrozole—breast cancer	0.023	0.045	CbGbCtD
Prasugrel—CYP2B6—Raloxifene—breast cancer	0.022	0.0431	CbGbCtD
Prasugrel—CYP2C19—Lapatinib—breast cancer	0.0185	0.0361	CbGbCtD
Prasugrel—CYP3A4—Exemestane—breast cancer	0.0177	0.0345	CbGbCtD
Prasugrel—CYP2C9—Idarubicin—breast cancer	0.0174	0.0341	CbGbCtD
Prasugrel—CYP3A4—Letrozole—breast cancer	0.015	0.0293	CbGbCtD
Prasugrel—CYP2B6—Tamoxifen—breast cancer	0.0146	0.0284	CbGbCtD
Prasugrel—CYP3A4—Anastrozole—breast cancer	0.0134	0.0262	CbGbCtD
Prasugrel—CYP3A4—Toremifene—breast cancer	0.0122	0.0239	CbGbCtD
Prasugrel—CYP3A4—Fulvestrant—breast cancer	0.0114	0.0222	CbGbCtD
Prasugrel—CYP2B6—Irinotecan—breast cancer	0.0112	0.0218	CbGbCtD
Prasugrel—ALB—Irinotecan—breast cancer	0.011	0.0214	CbGbCtD
Prasugrel—ALB—Fluorouracil—breast cancer	0.0105	0.0205	CbGbCtD
Prasugrel—CYP3A4—Thiotepa—breast cancer	0.0101	0.0198	CbGbCtD
Prasugrel—CYP2C9—Capecitabine—breast cancer	0.00955	0.0187	CbGbCtD
Prasugrel—CYP3A4—Ixabepilone—breast cancer	0.00927	0.0181	CbGbCtD
Prasugrel—CYP2C19—Tamoxifen—breast cancer	0.00925	0.0181	CbGbCtD
Prasugrel—CYP3A4—Lapatinib—breast cancer	0.00893	0.0175	CbGbCtD
Prasugrel—CYP2C9—Tamoxifen—breast cancer	0.00769	0.015	CbGbCtD
Prasugrel—CYP3A4—Raloxifene—breast cancer	0.00676	0.0132	CbGbCtD
Prasugrel—CYP2B6—Doxorubicin—breast cancer	0.0061	0.0119	CbGbCtD
Prasugrel—CYP2C9—Paclitaxel—breast cancer	0.00598	0.0117	CbGbCtD
Prasugrel—ALB—Methotrexate—breast cancer	0.0058	0.0113	CbGbCtD
Prasugrel—CYP2C9—Fluorouracil—breast cancer	0.00566	0.0111	CbGbCtD
Prasugrel—CYP3A4—Vinorelbine—breast cancer	0.00495	0.00968	CbGbCtD
Prasugrel—CYP3A4—Tamoxifen—breast cancer	0.00447	0.00874	CbGbCtD
Prasugrel—CYP3A4—Mitoxantrone—breast cancer	0.00436	0.00852	CbGbCtD
Prasugrel—CYP3A4—Paclitaxel—breast cancer	0.00348	0.0068	CbGbCtD
Prasugrel—CYP3A4—Irinotecan—breast cancer	0.00343	0.00671	CbGbCtD
Prasugrel—CYP3A4—Vinblastine—breast cancer	0.00305	0.00597	CbGbCtD
Prasugrel—CYP3A4—Docetaxel—breast cancer	0.00252	0.00492	CbGbCtD
Prasugrel—CES2—mammary gland—breast cancer	0.00199	0.0964	CbGeAlD
Prasugrel—CYP3A4—Doxorubicin—breast cancer	0.00187	0.00367	CbGbCtD
Prasugrel—P2RY12—epithelium—breast cancer	0.00174	0.0842	CbGeAlD
Prasugrel—CES2—nipple—breast cancer	0.00165	0.0797	CbGeAlD
Prasugrel—ALB—mammary gland—breast cancer	0.00114	0.0552	CbGeAlD
Prasugrel—P2RY12—endocrine gland—breast cancer	0.00109	0.0529	CbGeAlD
Prasugrel—CES2—skin of body—breast cancer	0.00106	0.0511	CbGeAlD
Prasugrel—CES2—endometrium—breast cancer	0.000996	0.0481	CbGeAlD
Prasugrel—CES2—uterus—breast cancer	0.000918	0.0444	CbGeAlD
Prasugrel—CES2—pituitary gland—breast cancer	0.000901	0.0436	CbGeAlD
Prasugrel—CES2—adipose tissue—breast cancer	0.000897	0.0434	CbGeAlD
Prasugrel—CES2—female reproductive system—breast cancer	0.000825	0.0399	CbGeAlD
Prasugrel—CES2—adrenal gland—breast cancer	0.000805	0.0389	CbGeAlD
Prasugrel—CES2—bone marrow—breast cancer	0.000779	0.0377	CbGeAlD
Prasugrel—CES2—female gonad—breast cancer	0.000751	0.0363	CbGeAlD
Prasugrel—CYP2C9—mammary gland—breast cancer	0.000713	0.0345	CbGeAlD
Prasugrel—CES2—endocrine gland—breast cancer	0.000698	0.0338	CbGeAlD
Prasugrel—Clopidogrel—CYP3A4—breast cancer	0.000589	0.546	CrCbGaD
Prasugrel—Clopidogrel—ABCB1—breast cancer	0.00049	0.454	CrCbGaD
Prasugrel—CES2—lymph node—breast cancer	0.000483	0.0233	CbGeAlD
Prasugrel—ALB—adrenal gland—breast cancer	0.000461	0.0223	CbGeAlD
Prasugrel—CYP2B6—skin of body—breast cancer	0.000381	0.0184	CbGeAlD
Prasugrel—CYP2C19—endocrine gland—breast cancer	0.000322	0.0156	CbGeAlD
Prasugrel—CYP2B6—female reproductive system—breast cancer	0.000298	0.0144	CbGeAlD
Prasugrel—CYP2C9—female reproductive system—breast cancer	0.000295	0.0143	CbGeAlD
Prasugrel—CYP2B6—adrenal gland—breast cancer	0.00029	0.014	CbGeAlD
Prasugrel—ALB—lymph node—breast cancer	0.000276	0.0134	CbGeAlD
Prasugrel—CYP2B6—endocrine gland—breast cancer	0.000252	0.0122	CbGeAlD
Prasugrel—CYP2C9—endocrine gland—breast cancer	0.000249	0.0121	CbGeAlD
Prasugrel—CYP3A4—female reproductive system—breast cancer	0.000225	0.0109	CbGeAlD
Prasugrel—CYP3A4—endocrine gland—breast cancer	0.00019	0.0092	CbGeAlD
Prasugrel—Urethral disorder—Capecitabine—breast cancer	0.000104	0.000745	CcSEcCtD
Prasugrel—Body temperature increased—Thiotepa—breast cancer	0.000103	0.000738	CcSEcCtD
Prasugrel—Headache—Vinblastine—breast cancer	0.000103	0.000737	CcSEcCtD
Prasugrel—Angioedema—Paclitaxel—breast cancer	0.000103	0.000737	CcSEcCtD
Prasugrel—Hypotension—Gemcitabine—breast cancer	0.000102	0.000734	CcSEcCtD
Prasugrel—Eye disorder—Docetaxel—breast cancer	0.000102	0.000734	CcSEcCtD
Prasugrel—Cerebrovascular accident—Doxorubicin—breast cancer	0.000101	0.000723	CcSEcCtD
Prasugrel—Dizziness—Goserelin—breast cancer	0.000101	0.000722	CcSEcCtD
Prasugrel—Hypotension—Fluorouracil—breast cancer	0.000101	0.000722	CcSEcCtD
Prasugrel—Leukopenia—Paclitaxel—breast cancer	0.000101	0.000722	CcSEcCtD
Prasugrel—Rash—Tamoxifen—breast cancer	0.0001	0.000721	CcSEcCtD
Prasugrel—Hypersensitivity—Vinorelbine—breast cancer	0.0001	0.000721	CcSEcCtD
Prasugrel—Dermatitis—Tamoxifen—breast cancer	0.0001	0.00072	CcSEcCtD
Prasugrel—Dyspnoea—Irinotecan—breast cancer	0.0001	0.000719	CcSEcCtD
Prasugrel—Dyspnoea—Mitoxantrone—breast cancer	0.0001	0.000719	CcSEcCtD
Prasugrel—Headache—Tamoxifen—breast cancer	9.98e-05	0.000716	CcSEcCtD
Prasugrel—Angiopathy—Docetaxel—breast cancer	9.92e-05	0.000712	CcSEcCtD
Prasugrel—Eye disorder—Capecitabine—breast cancer	9.89e-05	0.00071	CcSEcCtD
Prasugrel—Immune system disorder—Docetaxel—breast cancer	9.88e-05	0.000709	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	9.86e-05	0.000708	CcSEcCtD
Prasugrel—Pain in extremity—Doxorubicin—breast cancer	9.86e-05	0.000708	CcSEcCtD
Prasugrel—Mediastinal disorder—Docetaxel—breast cancer	9.85e-05	0.000707	CcSEcCtD
Prasugrel—Rash—Melphalan—breast cancer	9.83e-05	0.000706	CcSEcCtD
Prasugrel—Dermatitis—Melphalan—breast cancer	9.83e-05	0.000705	CcSEcCtD
Prasugrel—Cough—Paclitaxel—breast cancer	9.8e-05	0.000703	CcSEcCtD
Prasugrel—Asthenia—Vinorelbine—breast cancer	9.78e-05	0.000702	CcSEcCtD
Prasugrel—Dyspnoea—Gemcitabine—breast cancer	9.76e-05	0.000701	CcSEcCtD
Prasugrel—Nausea—Vinblastine—breast cancer	9.74e-05	0.000699	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Irinotecan—breast cancer	9.7e-05	0.000696	CcSEcCtD
Prasugrel—Hypertension—Paclitaxel—breast cancer	9.7e-05	0.000696	CcSEcCtD
Prasugrel—Fatigue—Mitoxantrone—breast cancer	9.69e-05	0.000695	CcSEcCtD
Prasugrel—Fatigue—Irinotecan—breast cancer	9.69e-05	0.000695	CcSEcCtD
Prasugrel—Angiopathy—Capecitabine—breast cancer	9.61e-05	0.000689	CcSEcCtD
Prasugrel—Dyspnoea—Fluorouracil—breast cancer	9.6e-05	0.000689	CcSEcCtD
Prasugrel—Rash—Goserelin—breast cancer	9.59e-05	0.000689	CcSEcCtD
Prasugrel—Hypersensitivity—Thiotepa—breast cancer	9.59e-05	0.000688	CcSEcCtD
Prasugrel—Dermatitis—Goserelin—breast cancer	9.58e-05	0.000688	CcSEcCtD
Prasugrel—Immune system disorder—Capecitabine—breast cancer	9.56e-05	0.000686	CcSEcCtD
Prasugrel—Mediastinal disorder—Capecitabine—breast cancer	9.54e-05	0.000685	CcSEcCtD
Prasugrel—Headache—Goserelin—breast cancer	9.53e-05	0.000684	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	9.5e-05	0.000682	CcSEcCtD
Prasugrel—Nausea—Tamoxifen—breast cancer	9.46e-05	0.000679	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Gemcitabine—breast cancer	9.45e-05	0.000678	CcSEcCtD
Prasugrel—Fatigue—Gemcitabine—breast cancer	9.44e-05	0.000677	CcSEcCtD
Prasugrel—Asthenia—Thiotepa—breast cancer	9.34e-05	0.00067	CcSEcCtD
Prasugrel—Diarrhoea—Vinorelbine—breast cancer	9.32e-05	0.000669	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Fluorouracil—breast cancer	9.29e-05	0.000667	CcSEcCtD
Prasugrel—Nausea—Melphalan—breast cancer	9.26e-05	0.000665	CcSEcCtD
Prasugrel—Back pain—Docetaxel—breast cancer	9.21e-05	0.000661	CcSEcCtD
Prasugrel—Anaphylactic shock—Paclitaxel—breast cancer	9.17e-05	0.000658	CcSEcCtD
Prasugrel—Nausea—Goserelin—breast cancer	9.04e-05	0.000649	CcSEcCtD
Prasugrel—Dizziness—Vinorelbine—breast cancer	9.01e-05	0.000647	CcSEcCtD
Prasugrel—Thrombocytopenia—Paclitaxel—breast cancer	8.97e-05	0.000644	CcSEcCtD
Prasugrel—Back pain—Capecitabine—breast cancer	8.91e-05	0.00064	CcSEcCtD
Prasugrel—Diarrhoea—Thiotepa—breast cancer	8.9e-05	0.000639	CcSEcCtD
Prasugrel—Skin disorder—Paclitaxel—breast cancer	8.9e-05	0.000639	CcSEcCtD
Prasugrel—Body temperature increased—Irinotecan—breast cancer	8.88e-05	0.000638	CcSEcCtD
Prasugrel—Body temperature increased—Mitoxantrone—breast cancer	8.88e-05	0.000638	CcSEcCtD
Prasugrel—Anaemia—Docetaxel—breast cancer	8.8e-05	0.000632	CcSEcCtD
Prasugrel—Body temperature increased—Gemcitabine—breast cancer	8.65e-05	0.000621	CcSEcCtD
Prasugrel—Dizziness—Thiotepa—breast cancer	8.61e-05	0.000618	CcSEcCtD
Prasugrel—Rash—Vinorelbine—breast cancer	8.59e-05	0.000617	CcSEcCtD
Prasugrel—Dermatitis—Vinorelbine—breast cancer	8.58e-05	0.000616	CcSEcCtD
Prasugrel—Hypotension—Paclitaxel—breast cancer	8.56e-05	0.000615	CcSEcCtD
Prasugrel—Headache—Vinorelbine—breast cancer	8.54e-05	0.000613	CcSEcCtD
Prasugrel—Leukopenia—Docetaxel—breast cancer	8.52e-05	0.000612	CcSEcCtD
Prasugrel—Anaemia—Capecitabine—breast cancer	8.52e-05	0.000611	CcSEcCtD
Prasugrel—Body temperature increased—Fluorouracil—breast cancer	8.51e-05	0.000611	CcSEcCtD
Prasugrel—Haematuria—Methotrexate—breast cancer	8.37e-05	0.000601	CcSEcCtD
Prasugrel—Cough—Docetaxel—breast cancer	8.31e-05	0.000596	CcSEcCtD
Prasugrel—Epistaxis—Methotrexate—breast cancer	8.28e-05	0.000594	CcSEcCtD
Prasugrel—Hypersensitivity—Irinotecan—breast cancer	8.28e-05	0.000594	CcSEcCtD
Prasugrel—Hypersensitivity—Mitoxantrone—breast cancer	8.28e-05	0.000594	CcSEcCtD
Prasugrel—Leukopenia—Capecitabine—breast cancer	8.25e-05	0.000592	CcSEcCtD
Prasugrel—Hypertension—Docetaxel—breast cancer	8.22e-05	0.00059	CcSEcCtD
Prasugrel—Rash—Thiotepa—breast cancer	8.21e-05	0.000589	CcSEcCtD
Prasugrel—Dermatitis—Thiotepa—breast cancer	8.2e-05	0.000588	CcSEcCtD
Prasugrel—Dyspnoea—Paclitaxel—breast cancer	8.17e-05	0.000587	CcSEcCtD
Prasugrel—Headache—Thiotepa—breast cancer	8.15e-05	0.000585	CcSEcCtD
Prasugrel—Nausea—Vinorelbine—breast cancer	8.09e-05	0.000581	CcSEcCtD
Prasugrel—Asthenia—Mitoxantrone—breast cancer	8.06e-05	0.000579	CcSEcCtD
Prasugrel—Asthenia—Irinotecan—breast cancer	8.06e-05	0.000579	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	8.05e-05	0.000578	CcSEcCtD
Prasugrel—Cough—Capecitabine—breast cancer	8.04e-05	0.000577	CcSEcCtD
Prasugrel—Hypertension—Capecitabine—breast cancer	7.96e-05	0.000571	CcSEcCtD
Prasugrel—Hypersensitivity—Fluorouracil—breast cancer	7.93e-05	0.000569	CcSEcCtD
Prasugrel—Haemoglobin—Methotrexate—breast cancer	7.92e-05	0.000569	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Paclitaxel—breast cancer	7.91e-05	0.000568	CcSEcCtD
Prasugrel—Fatigue—Paclitaxel—breast cancer	7.9e-05	0.000567	CcSEcCtD
Prasugrel—Haemorrhage—Methotrexate—breast cancer	7.88e-05	0.000566	CcSEcCtD
Prasugrel—Asthenia—Gemcitabine—breast cancer	7.85e-05	0.000564	CcSEcCtD
Prasugrel—Haematuria—Epirubicin—breast cancer	7.83e-05	0.000562	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	7.79e-05	0.000559	CcSEcCtD
Prasugrel—Urinary tract disorder—Methotrexate—breast cancer	7.78e-05	0.000559	CcSEcCtD
Prasugrel—Anaphylactic shock—Docetaxel—breast cancer	7.77e-05	0.000558	CcSEcCtD
Prasugrel—Epistaxis—Epirubicin—breast cancer	7.75e-05	0.000556	CcSEcCtD
Prasugrel—Nausea—Thiotepa—breast cancer	7.73e-05	0.000555	CcSEcCtD
Prasugrel—Urethral disorder—Methotrexate—breast cancer	7.73e-05	0.000555	CcSEcCtD
Prasugrel—Diarrhoea—Mitoxantrone—breast cancer	7.69e-05	0.000552	CcSEcCtD
Prasugrel—Diarrhoea—Irinotecan—breast cancer	7.69e-05	0.000552	CcSEcCtD
Prasugrel—Thrombocytopenia—Docetaxel—breast cancer	7.61e-05	0.000546	CcSEcCtD
Prasugrel—Skin disorder—Docetaxel—breast cancer	7.55e-05	0.000542	CcSEcCtD
Prasugrel—Bradycardia—Epirubicin—breast cancer	7.51e-05	0.000539	CcSEcCtD
Prasugrel—Diarrhoea—Gemcitabine—breast cancer	7.49e-05	0.000538	CcSEcCtD
Prasugrel—Dizziness—Irinotecan—breast cancer	7.43e-05	0.000533	CcSEcCtD
Prasugrel—Haemoglobin—Epirubicin—breast cancer	7.41e-05	0.000532	CcSEcCtD
Prasugrel—Haemorrhage—Epirubicin—breast cancer	7.38e-05	0.000529	CcSEcCtD
Prasugrel—Eye disorder—Methotrexate—breast cancer	7.37e-05	0.000529	CcSEcCtD
Prasugrel—Diarrhoea—Fluorouracil—breast cancer	7.36e-05	0.000529	CcSEcCtD
Prasugrel—Thrombocytopenia—Capecitabine—breast cancer	7.36e-05	0.000529	CcSEcCtD
Prasugrel—Skin disorder—Capecitabine—breast cancer	7.31e-05	0.000524	CcSEcCtD
Prasugrel—Urinary tract disorder—Epirubicin—breast cancer	7.28e-05	0.000523	CcSEcCtD
Prasugrel—Oedema peripheral—Epirubicin—breast cancer	7.27e-05	0.000522	CcSEcCtD
Prasugrel—Hypotension—Docetaxel—breast cancer	7.26e-05	0.000521	CcSEcCtD
Prasugrel—Haematuria—Doxorubicin—breast cancer	7.25e-05	0.00052	CcSEcCtD
Prasugrel—Body temperature increased—Paclitaxel—breast cancer	7.25e-05	0.00052	CcSEcCtD
Prasugrel—Urethral disorder—Epirubicin—breast cancer	7.23e-05	0.000519	CcSEcCtD
Prasugrel—Epistaxis—Doxorubicin—breast cancer	7.17e-05	0.000515	CcSEcCtD
Prasugrel—Angiopathy—Methotrexate—breast cancer	7.15e-05	0.000513	CcSEcCtD
Prasugrel—Immune system disorder—Methotrexate—breast cancer	7.12e-05	0.000511	CcSEcCtD
Prasugrel—Dizziness—Fluorouracil—breast cancer	7.12e-05	0.000511	CcSEcCtD
Prasugrel—Mediastinal disorder—Methotrexate—breast cancer	7.1e-05	0.00051	CcSEcCtD
Prasugrel—Rash—Mitoxantrone—breast cancer	7.09e-05	0.000509	CcSEcCtD
Prasugrel—Rash—Irinotecan—breast cancer	7.09e-05	0.000509	CcSEcCtD
Prasugrel—Dermatitis—Mitoxantrone—breast cancer	7.08e-05	0.000508	CcSEcCtD
Prasugrel—Dermatitis—Irinotecan—breast cancer	7.08e-05	0.000508	CcSEcCtD
Prasugrel—Headache—Irinotecan—breast cancer	7.04e-05	0.000505	CcSEcCtD
Prasugrel—Headache—Mitoxantrone—breast cancer	7.04e-05	0.000505	CcSEcCtD
Prasugrel—Hypotension—Capecitabine—breast cancer	7.03e-05	0.000505	CcSEcCtD
Prasugrel—Bradycardia—Doxorubicin—breast cancer	6.95e-05	0.000499	CcSEcCtD
Prasugrel—Dyspnoea—Docetaxel—breast cancer	6.93e-05	0.000497	CcSEcCtD
Prasugrel—Rash—Gemcitabine—breast cancer	6.9e-05	0.000495	CcSEcCtD
Prasugrel—Dermatitis—Gemcitabine—breast cancer	6.9e-05	0.000495	CcSEcCtD
Prasugrel—Eye disorder—Epirubicin—breast cancer	6.89e-05	0.000495	CcSEcCtD
Prasugrel—Haemoglobin—Doxorubicin—breast cancer	6.86e-05	0.000492	CcSEcCtD
Prasugrel—Headache—Gemcitabine—breast cancer	6.86e-05	0.000492	CcSEcCtD
Prasugrel—Haemorrhage—Doxorubicin—breast cancer	6.82e-05	0.00049	CcSEcCtD
Prasugrel—Rash—Fluorouracil—breast cancer	6.79e-05	0.000487	CcSEcCtD
Prasugrel—Dermatitis—Fluorouracil—breast cancer	6.78e-05	0.000487	CcSEcCtD
Prasugrel—Hypersensitivity—Paclitaxel—breast cancer	6.75e-05	0.000485	CcSEcCtD
Prasugrel—Headache—Fluorouracil—breast cancer	6.74e-05	0.000484	CcSEcCtD
Prasugrel—Urinary tract disorder—Doxorubicin—breast cancer	6.74e-05	0.000484	CcSEcCtD
Prasugrel—Oedema peripheral—Doxorubicin—breast cancer	6.72e-05	0.000483	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Docetaxel—breast cancer	6.71e-05	0.000481	CcSEcCtD
Prasugrel—Dyspnoea—Capecitabine—breast cancer	6.71e-05	0.000481	CcSEcCtD
Prasugrel—Fatigue—Docetaxel—breast cancer	6.7e-05	0.000481	CcSEcCtD
Prasugrel—Angiopathy—Epirubicin—breast cancer	6.69e-05	0.00048	CcSEcCtD
Prasugrel—Urethral disorder—Doxorubicin—breast cancer	6.69e-05	0.00048	CcSEcCtD
Prasugrel—Nausea—Mitoxantrone—breast cancer	6.68e-05	0.000479	CcSEcCtD
Prasugrel—Nausea—Irinotecan—breast cancer	6.68e-05	0.000479	CcSEcCtD
Prasugrel—Immune system disorder—Epirubicin—breast cancer	6.66e-05	0.000478	CcSEcCtD
Prasugrel—Mediastinal disorder—Epirubicin—breast cancer	6.65e-05	0.000477	CcSEcCtD
Prasugrel—Back pain—Methotrexate—breast cancer	6.64e-05	0.000476	CcSEcCtD
Prasugrel—Asthenia—Paclitaxel—breast cancer	6.58e-05	0.000472	CcSEcCtD
Prasugrel—Nausea—Gemcitabine—breast cancer	6.5e-05	0.000467	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Capecitabine—breast cancer	6.49e-05	0.000466	CcSEcCtD
Prasugrel—Fatigue—Capecitabine—breast cancer	6.48e-05	0.000465	CcSEcCtD
Prasugrel—Nausea—Fluorouracil—breast cancer	6.39e-05	0.000459	CcSEcCtD
Prasugrel—Eye disorder—Doxorubicin—breast cancer	6.38e-05	0.000458	CcSEcCtD
Prasugrel—Anaemia—Methotrexate—breast cancer	6.34e-05	0.000455	CcSEcCtD
Prasugrel—Diarrhoea—Paclitaxel—breast cancer	6.27e-05	0.00045	CcSEcCtD
Prasugrel—Back pain—Epirubicin—breast cancer	6.21e-05	0.000446	CcSEcCtD
Prasugrel—Angiopathy—Doxorubicin—breast cancer	6.19e-05	0.000444	CcSEcCtD
Prasugrel—Immune system disorder—Doxorubicin—breast cancer	6.16e-05	0.000442	CcSEcCtD
Prasugrel—Mediastinal disorder—Doxorubicin—breast cancer	6.15e-05	0.000441	CcSEcCtD
Prasugrel—Body temperature increased—Docetaxel—breast cancer	6.14e-05	0.000441	CcSEcCtD
Prasugrel—Leukopenia—Methotrexate—breast cancer	6.14e-05	0.000441	CcSEcCtD
Prasugrel—Dizziness—Paclitaxel—breast cancer	6.06e-05	0.000435	CcSEcCtD
Prasugrel—Cough—Methotrexate—breast cancer	5.99e-05	0.00043	CcSEcCtD
Prasugrel—Body temperature increased—Capecitabine—breast cancer	5.95e-05	0.000427	CcSEcCtD
Prasugrel—Anaemia—Epirubicin—breast cancer	5.93e-05	0.000426	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.8e-05	0.000416	CcSEcCtD
Prasugrel—Rash—Paclitaxel—breast cancer	5.78e-05	0.000415	CcSEcCtD
Prasugrel—Dermatitis—Paclitaxel—breast cancer	5.77e-05	0.000414	CcSEcCtD
Prasugrel—Leukopenia—Epirubicin—breast cancer	5.75e-05	0.000413	CcSEcCtD
Prasugrel—Back pain—Doxorubicin—breast cancer	5.75e-05	0.000412	CcSEcCtD
Prasugrel—Headache—Paclitaxel—breast cancer	5.74e-05	0.000412	CcSEcCtD
Prasugrel—Hypersensitivity—Docetaxel—breast cancer	5.72e-05	0.000411	CcSEcCtD
Prasugrel—Cough—Epirubicin—breast cancer	5.6e-05	0.000402	CcSEcCtD
Prasugrel—Anaphylactic shock—Methotrexate—breast cancer	5.6e-05	0.000402	CcSEcCtD
Prasugrel—Asthenia—Docetaxel—breast cancer	5.57e-05	0.0004	CcSEcCtD
Prasugrel—Hypertension—Epirubicin—breast cancer	5.54e-05	0.000398	CcSEcCtD
Prasugrel—Hypersensitivity—Capecitabine—breast cancer	5.54e-05	0.000398	CcSEcCtD
Prasugrel—Anaemia—Doxorubicin—breast cancer	5.49e-05	0.000394	CcSEcCtD
Prasugrel—Thrombocytopenia—Methotrexate—breast cancer	5.48e-05	0.000394	CcSEcCtD
Prasugrel—Nausea—Paclitaxel—breast cancer	5.44e-05	0.000391	CcSEcCtD
Prasugrel—Skin disorder—Methotrexate—breast cancer	5.44e-05	0.00039	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.43e-05	0.00039	CcSEcCtD
Prasugrel—Asthenia—Capecitabine—breast cancer	5.4e-05	0.000387	CcSEcCtD
Prasugrel—Leukopenia—Doxorubicin—breast cancer	5.32e-05	0.000382	CcSEcCtD
Prasugrel—Diarrhoea—Docetaxel—breast cancer	5.32e-05	0.000382	CcSEcCtD
Prasugrel—Anaphylactic shock—Epirubicin—breast cancer	5.24e-05	0.000376	CcSEcCtD
Prasugrel—Hypotension—Methotrexate—breast cancer	5.23e-05	0.000376	CcSEcCtD
Prasugrel—Cough—Doxorubicin—breast cancer	5.18e-05	0.000372	CcSEcCtD
Prasugrel—Diarrhoea—Capecitabine—breast cancer	5.15e-05	0.000369	CcSEcCtD
Prasugrel—Dizziness—Docetaxel—breast cancer	5.14e-05	0.000369	CcSEcCtD
Prasugrel—Thrombocytopenia—Epirubicin—breast cancer	5.13e-05	0.000368	CcSEcCtD
Prasugrel—Hypertension—Doxorubicin—breast cancer	5.13e-05	0.000368	CcSEcCtD
Prasugrel—Skin disorder—Epirubicin—breast cancer	5.09e-05	0.000365	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.02e-05	0.000361	CcSEcCtD
Prasugrel—Dyspnoea—Methotrexate—breast cancer	4.99e-05	0.000358	CcSEcCtD
Prasugrel—Dizziness—Capecitabine—breast cancer	4.97e-05	0.000357	CcSEcCtD
Prasugrel—Rash—Docetaxel—breast cancer	4.9e-05	0.000352	CcSEcCtD
Prasugrel—Hypotension—Epirubicin—breast cancer	4.9e-05	0.000351	CcSEcCtD
Prasugrel—Dermatitis—Docetaxel—breast cancer	4.89e-05	0.000351	CcSEcCtD
Prasugrel—Headache—Docetaxel—breast cancer	4.87e-05	0.000349	CcSEcCtD
Prasugrel—Anaphylactic shock—Doxorubicin—breast cancer	4.85e-05	0.000348	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Methotrexate—breast cancer	4.83e-05	0.000347	CcSEcCtD
Prasugrel—Fatigue—Methotrexate—breast cancer	4.83e-05	0.000347	CcSEcCtD
Prasugrel—Thrombocytopenia—Doxorubicin—breast cancer	4.75e-05	0.000341	CcSEcCtD
Prasugrel—Rash—Capecitabine—breast cancer	4.74e-05	0.00034	CcSEcCtD
Prasugrel—Dermatitis—Capecitabine—breast cancer	4.74e-05	0.00034	CcSEcCtD
Prasugrel—Headache—Capecitabine—breast cancer	4.71e-05	0.000338	CcSEcCtD
Prasugrel—Skin disorder—Doxorubicin—breast cancer	4.71e-05	0.000338	CcSEcCtD
Prasugrel—Dyspnoea—Epirubicin—breast cancer	4.67e-05	0.000335	CcSEcCtD
Prasugrel—Nausea—Docetaxel—breast cancer	4.61e-05	0.000331	CcSEcCtD
Prasugrel—Hypotension—Doxorubicin—breast cancer	4.53e-05	0.000325	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Epirubicin—breast cancer	4.52e-05	0.000325	CcSEcCtD
Prasugrel—Fatigue—Epirubicin—breast cancer	4.52e-05	0.000324	CcSEcCtD
Prasugrel—Nausea—Capecitabine—breast cancer	4.47e-05	0.000321	CcSEcCtD
Prasugrel—Body temperature increased—Methotrexate—breast cancer	4.43e-05	0.000318	CcSEcCtD
Prasugrel—Dyspnoea—Doxorubicin—breast cancer	4.32e-05	0.00031	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Doxorubicin—breast cancer	4.19e-05	0.0003	CcSEcCtD
Prasugrel—Fatigue—Doxorubicin—breast cancer	4.18e-05	0.0003	CcSEcCtD
Prasugrel—Body temperature increased—Epirubicin—breast cancer	4.14e-05	0.000297	CcSEcCtD
Prasugrel—Hypersensitivity—Methotrexate—breast cancer	4.13e-05	0.000296	CcSEcCtD
Prasugrel—Asthenia—Methotrexate—breast cancer	4.02e-05	0.000288	CcSEcCtD
Prasugrel—Hypersensitivity—Epirubicin—breast cancer	3.86e-05	0.000277	CcSEcCtD
Prasugrel—Body temperature increased—Doxorubicin—breast cancer	3.83e-05	0.000275	CcSEcCtD
Prasugrel—Diarrhoea—Methotrexate—breast cancer	3.83e-05	0.000275	CcSEcCtD
Prasugrel—Asthenia—Epirubicin—breast cancer	3.76e-05	0.00027	CcSEcCtD
Prasugrel—Dizziness—Methotrexate—breast cancer	3.7e-05	0.000266	CcSEcCtD
Prasugrel—Diarrhoea—Epirubicin—breast cancer	3.59e-05	0.000257	CcSEcCtD
Prasugrel—Hypersensitivity—Doxorubicin—breast cancer	3.57e-05	0.000256	CcSEcCtD
Prasugrel—Rash—Methotrexate—breast cancer	3.53e-05	0.000253	CcSEcCtD
Prasugrel—Dermatitis—Methotrexate—breast cancer	3.53e-05	0.000253	CcSEcCtD
Prasugrel—Headache—Methotrexate—breast cancer	3.51e-05	0.000252	CcSEcCtD
Prasugrel—Asthenia—Doxorubicin—breast cancer	3.48e-05	0.00025	CcSEcCtD
Prasugrel—Dizziness—Epirubicin—breast cancer	3.47e-05	0.000249	CcSEcCtD
Prasugrel—Nausea—Methotrexate—breast cancer	3.33e-05	0.000239	CcSEcCtD
Prasugrel—Diarrhoea—Doxorubicin—breast cancer	3.32e-05	0.000238	CcSEcCtD
Prasugrel—Rash—Epirubicin—breast cancer	3.3e-05	0.000237	CcSEcCtD
Prasugrel—Dermatitis—Epirubicin—breast cancer	3.3e-05	0.000237	CcSEcCtD
Prasugrel—Headache—Epirubicin—breast cancer	3.28e-05	0.000236	CcSEcCtD
Prasugrel—Dizziness—Doxorubicin—breast cancer	3.21e-05	0.00023	CcSEcCtD
Prasugrel—Nausea—Epirubicin—breast cancer	3.11e-05	0.000223	CcSEcCtD
Prasugrel—Rash—Doxorubicin—breast cancer	3.06e-05	0.000219	CcSEcCtD
Prasugrel—Dermatitis—Doxorubicin—breast cancer	3.05e-05	0.000219	CcSEcCtD
Prasugrel—Headache—Doxorubicin—breast cancer	3.04e-05	0.000218	CcSEcCtD
Prasugrel—Nausea—Doxorubicin—breast cancer	2.88e-05	0.000207	CcSEcCtD
Prasugrel—CYP3A4—Metabolism—NME1—breast cancer	5.21e-06	5.61e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ADSL—breast cancer	5.21e-06	5.61e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—UMPS—breast cancer	5.21e-06	5.61e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PHGDH—breast cancer	5.21e-06	5.61e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC2A2—breast cancer	5.2e-06	5.59e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—breast cancer	5.19e-06	5.58e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—FASN—breast cancer	5.18e-06	5.57e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TGFB1—breast cancer	5.18e-06	5.57e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—BCHE—breast cancer	5.16e-06	5.55e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	5.15e-06	5.54e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—BRIP1—breast cancer	5.11e-06	5.5e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HPSE—breast cancer	5.11e-06	5.5e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LDHB—breast cancer	5.11e-06	5.5e-05	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	5.11e-06	5.5e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ABCG2—breast cancer	5.09e-06	5.48e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CPT1A—breast cancer	5.09e-06	5.48e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—MTR—breast cancer	5.09e-06	5.48e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC5A5—breast cancer	5.09e-06	5.48e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGFR—breast cancer	5.08e-06	5.46e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP17A1—breast cancer	5.03e-06	5.41e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HPGDS—breast cancer	5e-06	5.37e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS1—breast cancer	4.98e-06	5.36e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ENO1—breast cancer	4.98e-06	5.36e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HBA1—breast cancer	4.96e-06	5.34e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.96e-06	5.34e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NQO1—breast cancer	4.92e-06	5.29e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC2A1—breast cancer	4.92e-06	5.29e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.9e-06	5.27e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—COMT—breast cancer	4.9e-06	5.27e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP2D6—breast cancer	4.88e-06	5.25e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTP1—breast cancer	4.87e-06	5.24e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IL2—breast cancer	4.86e-06	5.23e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HMMR—breast cancer	4.85e-06	5.21e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA3—breast cancer	4.85e-06	5.21e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCC1—breast cancer	4.85e-06	5.21e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTT1—breast cancer	4.85e-06	5.21e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ACHE—breast cancer	4.85e-06	5.21e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.82e-06	5.18e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—HMOX1—breast cancer	4.81e-06	5.17e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP3A4—breast cancer	4.8e-06	5.16e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ITPR1—breast cancer	4.8e-06	5.16e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KRAS—breast cancer	4.8e-06	5.16e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NCOA2—breast cancer	4.79e-06	5.16e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.77e-06	5.13e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP1B1—breast cancer	4.72e-06	5.07e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.69e-06	5.05e-05	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	4.69e-06	5.05e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—FASN—breast cancer	4.65e-06	5e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—BCHE—breast cancer	4.63e-06	4.98e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HSP90AA1—breast cancer	4.63e-06	4.98e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ABCB1—breast cancer	4.61e-06	4.96e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP17A1—breast cancer	4.59e-06	4.93e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC5A5—breast cancer	4.57e-06	4.92e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ENO1—breast cancer	4.54e-06	4.88e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS1—breast cancer	4.54e-06	4.88e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—TYMS—breast cancer	4.53e-06	4.87e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.52e-06	4.87e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NCOA1—breast cancer	4.5e-06	4.84e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PLA2G4A—breast cancer	4.48e-06	4.82e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTM1—breast cancer	4.48e-06	4.82e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—NCOR1—breast cancer	4.48e-06	4.82e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.47e-06	4.8e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP2D6—breast cancer	4.45e-06	4.79e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP19A1—breast cancer	4.43e-06	4.77e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—STK11—breast cancer	4.43e-06	4.77e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA4—breast cancer	4.43e-06	4.77e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CA9—breast cancer	4.43e-06	4.77e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NQO1—breast cancer	4.42e-06	4.75e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC2A1—breast cancer	4.42e-06	4.75e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CA—breast cancer	4.41e-06	4.74e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NCOA2—breast cancer	4.37e-06	4.7e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.32e-06	4.65e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GPX2—breast cancer	4.32e-06	4.65e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA2—breast cancer	4.32e-06	4.65e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP3A4—breast cancer	4.31e-06	4.63e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GPX1—breast cancer	4.29e-06	4.61e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.28e-06	4.61e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SULT1A1—breast cancer	4.27e-06	4.59e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GPX4—breast cancer	4.27e-06	4.59e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—breast cancer	4.26e-06	4.58e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP1A1—breast cancer	4.25e-06	4.57e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SRC—breast cancer	4.24e-06	4.56e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—FASN—breast cancer	4.24e-06	4.56e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP1B1—breast cancer	4.23e-06	4.55e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—BCHE—breast cancer	4.22e-06	4.54e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ERCC2—breast cancer	4.21e-06	4.53e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC5A5—breast cancer	4.17e-06	4.49e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—IDH1—breast cancer	4.17e-06	4.48e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTA1—breast cancer	4.17e-06	4.48e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.16e-06	4.48e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HSP90AA1—breast cancer	4.15e-06	4.47e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—breast cancer	4.13e-06	4.44e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—COMT—breast cancer	4.12e-06	4.43e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NAT2—breast cancer	4.12e-06	4.43e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTP1—breast cancer	4.1e-06	4.41e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HRAS—breast cancer	4.08e-06	4.38e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HMOX1—breast cancer	4.05e-06	4.35e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NCOA1—breast cancer	4.04e-06	4.35e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ITPR1—breast cancer	4.04e-06	4.34e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC2A1—breast cancer	4.03e-06	4.33e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NQO1—breast cancer	4.03e-06	4.33e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—STK11—breast cancer	3.98e-06	4.28e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP19A1—breast cancer	3.98e-06	4.28e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—MTHFR—breast cancer	3.96e-06	4.26e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.94e-06	4.24e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP3A4—breast cancer	3.93e-06	4.22e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.91e-06	4.2e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MAPK3—breast cancer	3.91e-06	4.2e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL6—breast cancer	3.9e-06	4.2e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ABCB1—breast cancer	3.88e-06	4.18e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP1B1—breast cancer	3.86e-06	4.15e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—TYMS—breast cancer	3.81e-06	4.1e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TGFB1—breast cancer	3.79e-06	4.08e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.79e-06	4.07e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NCOR1—breast cancer	3.77e-06	4.06e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTM1—breast cancer	3.77e-06	4.06e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PLA2G4A—breast cancer	3.77e-06	4.06e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.74e-06	4.02e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—COMT—breast cancer	3.7e-06	3.98e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTP1—breast cancer	3.68e-06	3.96e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NCOA1—breast cancer	3.68e-06	3.96e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CAV1—breast cancer	3.65e-06	3.93e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HMOX1—breast cancer	3.63e-06	3.91e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—STK11—breast cancer	3.63e-06	3.9e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP19A1—breast cancer	3.63e-06	3.9e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ITPR1—breast cancer	3.62e-06	3.9e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—MED12—breast cancer	3.61e-06	3.89e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—DPYD—breast cancer	3.61e-06	3.89e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GPX1—breast cancer	3.61e-06	3.88e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—AKT1—breast cancer	3.6e-06	3.87e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP1A1—breast cancer	3.57e-06	3.85e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALDOA—breast cancer	3.56e-06	3.83e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ERCC2—breast cancer	3.54e-06	3.81e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—KRAS—breast cancer	3.51e-06	3.78e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ABCB1—breast cancer	3.49e-06	3.75e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NCOA3—breast cancer	3.45e-06	3.72e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC2A2—breast cancer	3.43e-06	3.69e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—TYMS—breast cancer	3.42e-06	3.68e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.41e-06	3.67e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.38e-06	3.64e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTM1—breast cancer	3.38e-06	3.64e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NCOR1—breast cancer	3.38e-06	3.64e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—COMT—breast cancer	3.37e-06	3.63e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CPT1A—breast cancer	3.36e-06	3.61e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—MTR—breast cancer	3.36e-06	3.61e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCG2—breast cancer	3.36e-06	3.61e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTP1—breast cancer	3.36e-06	3.61e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—MTHFR—breast cancer	3.33e-06	3.58e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CG—breast cancer	3.33e-06	3.58e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HMOX1—breast cancer	3.31e-06	3.56e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ITPR1—breast cancer	3.3e-06	3.56e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HPGDS—breast cancer	3.29e-06	3.54e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HBA1—breast cancer	3.27e-06	3.52e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GPX1—breast cancer	3.24e-06	3.49e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CA—breast cancer	3.23e-06	3.47e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP1A1—breast cancer	3.21e-06	3.45e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTT1—breast cancer	3.2e-06	3.44e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ACHE—breast cancer	3.2e-06	3.44e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ERCC2—breast cancer	3.18e-06	3.42e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ABCB1—breast cancer	3.18e-06	3.42e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—TYMS—breast cancer	3.12e-06	3.36e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—breast cancer	3.12e-06	3.36e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.09e-06	3.32e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NCOR1—breast cancer	3.09e-06	3.32e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTM1—breast cancer	3.09e-06	3.32e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CAV1—breast cancer	3.07e-06	3.31e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP17A1—breast cancer	3.02e-06	3.25e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ENO1—breast cancer	2.99e-06	3.22e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS1—breast cancer	2.99e-06	3.22e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—MTHFR—breast cancer	2.99e-06	3.22e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—HRAS—breast cancer	2.98e-06	3.21e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GPX1—breast cancer	2.96e-06	3.18e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.94e-06	3.16e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP2D6—breast cancer	2.94e-06	3.16e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP1A1—breast cancer	2.93e-06	3.15e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CD—breast cancer	2.92e-06	3.15e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ERCC2—breast cancer	2.9e-06	3.12e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALB—breast cancer	2.89e-06	3.11e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NCOA2—breast cancer	2.88e-06	3.1e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CG—breast cancer	2.8e-06	3.01e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—FASN—breast cancer	2.8e-06	3.01e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—BCHE—breast cancer	2.78e-06	2.99e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—NOS3—breast cancer	2.76e-06	2.97e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CAV1—breast cancer	2.76e-06	2.97e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC5A5—breast cancer	2.75e-06	2.96e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—MTHFR—breast cancer	2.73e-06	2.93e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC2A1—breast cancer	2.66e-06	2.86e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NQO1—breast cancer	2.66e-06	2.86e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.64e-06	2.84e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—AKT1—breast cancer	2.63e-06	2.83e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CB—breast cancer	2.55e-06	2.74e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP1B1—breast cancer	2.55e-06	2.74e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS2—breast cancer	2.53e-06	2.72e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CAV1—breast cancer	2.52e-06	2.71e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CG—breast cancer	2.51e-06	2.7e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.5e-06	2.69e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CD—breast cancer	2.46e-06	2.65e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NCOA1—breast cancer	2.43e-06	2.61e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.4e-06	2.59e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP19A1—breast cancer	2.39e-06	2.58e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—STK11—breast cancer	2.39e-06	2.58e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NOS3—breast cancer	2.32e-06	2.5e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CG—breast cancer	2.29e-06	2.47e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—COMT—breast cancer	2.23e-06	2.39e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTP1—breast cancer	2.21e-06	2.38e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CD—breast cancer	2.21e-06	2.38e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTEN—breast cancer	2.2e-06	2.37e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HMOX1—breast cancer	2.18e-06	2.35e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALB—breast cancer	2.18e-06	2.35e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ITPR1—breast cancer	2.18e-06	2.34e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CB—breast cancer	2.15e-06	2.31e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS2—breast cancer	2.13e-06	2.29e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCB1—breast cancer	2.1e-06	2.26e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NOS3—breast cancer	2.09e-06	2.24e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—TYMS—breast cancer	2.06e-06	2.22e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NCOR1—breast cancer	2.04e-06	2.19e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTM1—breast cancer	2.04e-06	2.19e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.04e-06	2.19e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CD—breast cancer	2.01e-06	2.17e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALB—breast cancer	1.99e-06	2.14e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GPX1—breast cancer	1.95e-06	2.1e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP1A1—breast cancer	1.93e-06	2.08e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CB—breast cancer	1.93e-06	2.07e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ERCC2—breast cancer	1.91e-06	2.06e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS2—breast cancer	1.91e-06	2.05e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NOS3—breast cancer	1.9e-06	2.05e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTEN—breast cancer	1.85e-06	1.99e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—MTHFR—breast cancer	1.8e-06	1.94e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CB—breast cancer	1.76e-06	1.89e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS2—breast cancer	1.74e-06	1.87e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTEN—breast cancer	1.66e-06	1.79e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CAV1—breast cancer	1.66e-06	1.78e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CA—breast cancer	1.55e-06	1.67e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTEN—breast cancer	1.52e-06	1.63e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CG—breast cancer	1.51e-06	1.63e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CD—breast cancer	1.33e-06	1.43e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALB—breast cancer	1.31e-06	1.41e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CA—breast cancer	1.31e-06	1.41e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AKT1—breast cancer	1.27e-06	1.37e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NOS3—breast cancer	1.25e-06	1.35e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CA—breast cancer	1.17e-06	1.26e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CB—breast cancer	1.16e-06	1.25e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS2—breast cancer	1.15e-06	1.23e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CA—breast cancer	1.07e-06	1.15e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AKT1—breast cancer	1.07e-06	1.15e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTEN—breast cancer	1e-06	1.08e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AKT1—breast cancer	9.59e-07	1.03e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AKT1—breast cancer	8.74e-07	9.41e-06	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CA—breast cancer	7.06e-07	7.59e-06	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AKT1—breast cancer	5.77e-07	6.2e-06	CbGpPWpGaD
